Reliability and validity of the Screening Tool for Assessment of Psychosocial Problems
Journal Title: Open Journal of Psychiatry & Allied Sciences - Year 2019, Vol 10, Issue 2
Abstract
Background: While working in a multidisciplinary team, many a time there is lack of clarity or connivance who will work on what issue and how to decide about a referral to another team member, particularly to the psychiatric social worker. So, a need was felt to develop a screening tool for the same purpose. Aim: To develop a screening tool for the assessment of psychosocial problems, and to test its reliability and validity. Methods: A 12-item scale was developed following the scientific tool development steps. Content validity of the tool was established by accepting more than 70% validity index for each item. To test the reliability, it was applied to 100 family members of persons with mental illness. Results: Statistical analyses showed good internal consistency by Cronbach’s alpha (r=0.76) and Spearman-Brown prophecy formula (r=0.73). Scores of all the 12 individual items significantly correlated with the total score of the tool indicating acceptable sensitivity. A significant correlation was found among the scores of items indicating good construct validity of the tool. Conclusion: The Screening Tool for Assessment of Psychosocial Problems (STAPP) is a brief and simple to use instrument, which has acceptable psychometric properties (valid and reliable). It is suitable for screening of the psychosocial problems of family members of person with a mental illness. It can be used for screening in routine clinical practice.
Authors and Affiliations
Kamlesh Kumar Sahu, Bir Singh Chavan, Chandra Bala, Shikha Tyagi
Keywords
Related Articles
- EP ID EP596395
- DOI 10.5958/2394-2061.2019.00039.9
- Views 86
- Downloads 0
SoMHiL and OJPAS™: “like a rolling stone”
The Society of Mental Health in LAMIC (SoMHiL) and Academia Dysphrenia come together to run the Open Journal of Psychiatry & Allied Sciences (OJPAS™). The Editor-in-Chief is going to change from the upcoming issue.
Serum prolactin level in patients taking olanzapine
Introduction: Olanzapine is a commonly used antipsychotic. Prolactin elevation is a common adverse effect of anstipsychotics, and serum prolactin elevation is seen in about 30% patients treated with olanzapine. There are...
Methamphetamine: symptoms under the bridge
This case report discusses the abuse of methamphetamine in North East India.
Impact of depression on quality of life of patients having history of recent myocardial infarction
Background: Major depressive disorder is very common in patients having history of myocardial infarction (MI). Quality of life (QOL) is seen to be poorer in persons having post MI depression than who are non depressed....
Fluoxetine-induced blurring of vision: a rare ocular side effect
A young male presented with second episode of depressive symptoms of one month duration; treatment started with fluoxetine and on third week of starting of treatment, he developed sudden onset blurring of vision due to m...